New Jersey · 2026-2027 Regular Session · Bill

S 4210: Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.

In committee Last action June 11, 2026: Combined with S4194 (SCS)

Plain-language summary

S 4210 is a bill introduced in the New Jersey Senate on May 11, 2026. According to its official title, it concerns: Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder. Primary sponsor: Raj Mukherji (Democratic). Most recent recorded action (June 11, 2026): Combined with S4194 (SCS).

Sponsors

Primary sponsor: Raj Mukherji (Democratic).